U.S. Healthcare Undervalued Stocks Based On Cash Flows

DexCom

Market Cap: US$24.8b

A medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally.

TransMedics Group

Market Cap: US$5.0b

A commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally.

Privia Health Group

Market Cap: US$3.0b

Operates as a national physician-enablement company in the United States.

GeneDx Holdings

Market Cap: US$4.8b

A genomics company, provides genetic testing services.

Hims & Hers Health

Market Cap: US$9.1b

Operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally.

KORU Medical Systems

Market Cap: US$274.2m

Develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally.

STAAR Surgical

Market Cap: US$1.3b

Designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye.

Waystar Holding

Market Cap: US$7.1b

Develops a cloud-based software solution for healthcare payments.

Alphatec Holdings

Market Cap: US$3.3b

A medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally.